Horizon Therapeutics Ltd - Company Profile

Powered by

All the sales intelligence you need on Horizon Therapeutics Ltd in one solution.

$395 $295
Register your interest Learn more
  • Save hours of research time with a comprehensive
    Sales Intelligence Solution.

  • Understand how Horizon Therapeutics Ltd fits into your total
    addressable market and Ideal Customer Profile.

  • Gain competitive edge with triggers that tell you
    when and how to engage with Horizon Therapeutics Ltd.

Back to companies

Horizon Therapeutics Ltd: Overview

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

Horizon Therapeutics Ltd, a subsidiary of Amgen Inc, operates within the pharmaceuticals and healthcare industry, specifically focusing on technology services. It specializes in research and development (R&D) in the field of biotechnology. The company is headquartered in Ireland.

 Gain a 360-degree view of Horizon Therapeutics Ltd and make more informed decisions for your business Gain a 360-degree view of Horizon Therapeutics Ltd and make more informed decisions for your business Learn more
Headquarters Ireland
Address 70 St. Stephen's Green, Saint Kevin's, Dublin 2, D02E2X4
Website www.horizontherapeutics.com
Telephone 353 1 7722100
No of Employees 2,190
Industry Pharmaceuticals and Healthcare
Revenue (2022) $3.6B
   
   
Gain access to our premium signals and make informed decisions for your business Gain access to our premium signals and make informed decisions for your business Learn more

Horizon Therapeutics Ltd premium industry data and analytics

130+

Clinical Trials

Determine Horizon Therapeutics Ltd go-to-market proposition and gain insight into the company’s clinical operations, recruitment, and trial strategy.

130+

Catalyst Calendar

Proactively evaluate Horizon Therapeutics Ltd’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.

100+

Lead Sheet

Understand when and why to target accounts of prospective leads, as well as who to reach out to, drawing on intelligence for Horizon Therapeutics Ltd’s relevant decision makers and contact details.

40+

Pipeline Drugs

Identify which of Horizon Therapeutics Ltd’s products will be commercialized, helping you to better contend with shifting product portfolios, and allowing you to stay one step ahead of the market.

20+

Insights

Remove risk and uncertainty, gain a competitive edge and secure actionable leads with access to company-related investigative journalist content.

20+

Sales & Consensus Forecasts

Understand the current and future drug revenue for Horizon Therapeutics Ltd and assess market opportunity for new entrants with patient population 8-year forecasts.

13+

Regulatory Milestones

Track drug and patent expiries along with geographies impacted.

12+

Marketed Drugs

Understand Horizon Therapeutics Ltd’s commercialized product portfolio to stay one step ahead of the market.

1

IT Services Contracts

Improve competitive bidding with insights into all publicly disclosed IT services contracts for Horizon Therapeutics Ltd (including IT outsourcing, business process outsourcing, systems integration & consulting and more).

1

ICT Spend & Tech Priorities

IT Client Prospector provides intelligence on Horizon Therapeutics Ltd’s likely spend across technology areas enabling you to understand the digital strategy.

Image for loader
Executives
Name Position Board Since Age
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Non Dignissim Eros Proin vel Convallis 2026 XY
Gain insight into Horizon Therapeutics Ltd key executives to enhance your sales strategy Gain insight into Horizon Therapeutics Ltd key executives to enhance your sales strategy Learn more
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer

Why are you leaving?